MedTrace Logo

Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women

NCT03916978 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-12-27

No results posted yet for this study

Summary

Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve hormonal profile of women in menopause.

Conditions

  • Infertility, Female
  • Anovulatory Infertility
  • Menopause
  • Amenorrhea

Interventions

BIOLOGICAL

Autologous PRP intra ovarian infusion

Autologous PRP intra ovarian infusion

BIOLOGICAL

Autologous PFP intra ovarian infusion

Autologous PFP intra ovarian infusion

Sponsors & Collaborators

  • National and Kapodistrian University of Athens

    collaborator OTHER

  • Genesis Athens Clinic

    lead OTHER

Principal Investigators

  • Agni Pantou, MD · Centre of Human Reproduction, Genesis Athens Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-21
Primary Completion
2026-01-30
Completion
2026-07-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03916978 on ClinicalTrials.gov